NCT06152042 Phase 2 Completed
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus Study sponsor: Biomea Fusion Inc. · BMEA
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2025-05-20 Actual
Enrollment · participants 37 Actual
Source updated 2026-08-28 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology